Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma
Autor
Lu, Tong
Xu, Ran
Wang, Chenghao
Zhou, Xiang
Parra-Medina, Rafael
Díaz-Peña, Roberto
Peng, Bo
Zhang, Linyou
Resumen
Background: Lung adenocarcinoma (LUAD) is a prevalent subtype of lung cancer associated with high mortality rates. We aimed to utilize single-cell multiomics analysis to identify the key molecules involved in ubiquitination modification, which plays a role in LUAD development and progression. Methods: We use a systematic approach to analyze LUAD-related single-cell and bulk transcriptome datasets from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Single-cell RNA sequencing (scRNA-seq) data were normalized, clustered, and annotated with the Seurat package in R. InferCNV was used to distinguish malignant from epithelial cells, and AUCell evaluated the area under the curve (AUC) score of ubiquitination-related enzymes. Survival and differential analyses identified significant molecular markers associated with ubiquitination. PSMD14 expression was confirmed using reverse-transcription quantitative polymerase chain reaction (RT-qPCR) and Western blot assays, and its knockdown cell lines were assessed for effects on cellular processes and tumor formation in mice. PSMD14’s interacting proteins were predicted, and its impact on AGR2 protein half-life and ubiquitination was evaluated. Rescue experiments involving PSMD14 overexpression and AGR2 silencing assessed their impact on malignant behaviors. Results: By means of single-cell sequencing analysis, we probed the ubiquitination modification landscape in the LUAD microenvironment. Malignant cells had elevated scores for enzymes and ubiquitin-binding domains compared to normal epithelial cells, with 53 ubiquitination-related molecules showing prognostic disparities. FGR, PSMD14, and ZBTB16 were identified as genes with prognostic significance, with PSMD14 showing higher expression in epithelial and malignant cells. Two missense mutation sites were identified in PSMD14, which had a high copy number amplification ratio and positive correlation with messenger RNA (mRNA) expression. PSMD14 expression and tumor stage were found to be independent prognostic factors, and interfering with PSMD14 expression reduced the malignant behavior of LUAD cells. PSMD14 was found to bind to AGR2 protein and reduce its ubiquitination, leading to increased AGR2 stability. Knockdown of AGR2 inhibited the enhancement of cell viability, invasion, and migration resulting from PSMD14 overexpression. Conclusions: This study examined ubiquitination modifications in LUAD using sequencing data, identifying PSMD14’s critical role in malignancy regulation and its potential as a prognostic and therapeutic biomarker. These insights enhance understanding of LUAD mechanisms and treatment. © Journal of Thoracic Disease. All rights reserved.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Computational analysis and functional prediction of ubiquitin hypothetical protein: A possible target in parkinson disease (2020)
Barragán-Osorio L.; Giraldo G.; Alméciga-Diaz C.J.; Aliev G.; Barreto G.E.; Gonzalez J. (Bentham Science Publishers, 2016) -
Article
Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study (2024)
Rapado-González, Óscar; Brea-Iglesias, Jenifer; Rodríguez-Casanova, Aitor; Bao-Caamano, Aida; López-Cedrún, José-Luis; Triana-Martínez, Gabriel; Díaz-Peña, Roberto; Santos, María Arminda; López-López, Rafael; Muinelo-Romay, Laura; ... (John Wiley and Sons Inc, 2023)Background: We explore the utility of TruSight Tumor 170 panel (TST170) for detecting somatic mutations in tumor and cfDNA from locoregional recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Methods: ... -
Article
rs2802292 polymorphism in the FOXO3A gene and exceptional longevity in two ethnically distinct cohorts (2020)
Fuku N.; Díaz-Peña R.; Arai Y.; Abe Y.; Pareja-Galeano H.; Sanchis-Gomar F.; Santos-Lozano A.; Zempo H.; Naito H.; Murakami H.; ... (Elsevier Ireland Ltd, 2016)